FDA Drug Recalls

Recalls / Class II

Class IID-0254-2026

Product

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

Brand name
Oxycodone And Acetaminophen
Generic name
Oxycodone Hydrochloride And Acetaminophen
Active ingredients
Acetaminophen, Oxycodone Hydrochloride
Route
Oral
NDCs
0406-0512, 0406-0522, 0406-0523
FDA application
ANDA087463
Affected lot / code info
Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.

Why it was recalled

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Recalling firm

Firm
SpecGx, LLC
Manufacturer
SpecGx LLC
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
385 Marshall Ave, Webster Groves, Missouri 63119-1831

Distribution

Quantity
287,988 Bottles.
Distribution pattern
Nationwide

Timeline

Recall initiated
2025-12-16
FDA classified
2026-01-07
Posted by FDA
2026-01-14
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0254-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.